EKTERLY
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for EKTERLY, covering 2025-07-03 to 2026-07-14. Get the full timeline:
Most recent: EMA Authorised: Ekterly (sebetralstat) — Kalvista Pharmaceuticals (Ireland) Limited